Gene Therapy: A 'One and Done' Hemophilia B Treatment?
Nearly all patients treated with a one-time gene therapy shot for hemophilia B were able to discontinue full-dose bleeding prophylaxis, says a study. Annual bleed rates fell by 64% after the lead-in period. Medscape Medical News